ABLD — AbL Diagnostics SA Cashflow Statement
0.000.00%
- €39.21m
- €40.14m
- €6.95m
Annual cashflow statement for AbL Diagnostics SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | — | 12 M |
| Source: | ARS | Interim Report | ARS | ARS | |
| Standards: | FAS | FAS | FAS | — | FAS |
| Status: | Final | Final | Final | fx Preliminary | Final |
| Net Income/Starting Line | 0.258 | 1.11 | 0.054 | — | 0.987 |
| Depreciation | |||||
| Non-Cash Items | -0.398 | 1.89 | -0.272 | — | -0.104 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.084 | -3.05 | 1.14 | — | 0.014 |
| Change in Accounts Payable | |||||
| Net Change in Other Assets & Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -0.057 | -0.054 | 0.926 | — | 1.51 |
| Capital Expenditures | — | -1.84 | -0.939 | — | -0.793 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0.4 | 0.345 | 0.411 | — | 0.04 |
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 0.4 | -1.49 | -0.528 | — | -0.752 |
| Financing Cash Flow Items | 0 | — | — | — | 1.09 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0 | -0.143 | 0.813 | — | 0.032 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.343 | -1.69 | 1.21 | — | 0.787 |